Quantinno Capital Management LP
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1759654
NEW YORK, NY
Position in AMLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,452,066
New position
Shares Held
80,850
first reported quarter
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 207 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $225,769,469 across 37 Drug Manufacturers - Specialty & Generic names. AMLX ranks #18 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
1,974,908 | $48,602,485 | |
| 2 | ZTS |
Zoetis Inc.
|
400,665 | $28,791,786 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,402,650 | $22,484,479 | |
| 4 | VTRS |
Viatris Inc
|
1,368,433 | $21,730,716 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
27,122 | $14,695,513 | |
| 6 | PRGO |
PERRIGO Co plc
|
1,369,736 | $14,231,557 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
79,655 | $13,425,053 | |
| 8 | HLN |
Haleon plc
|
1,151,189 | $10,740,593 |
All Filings in AMLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,452,066 | 80,850 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||